CAS: 78081-87-5; Fmoc-Lys(Fmoc)-Oh

该化合物是氨酸甘油的一种受保护形式,通常用于peptide合成和生物合成."fmoc"(9-氟戊基甲基碳酸基)组群是氨基功能的保护群体,允许有选择的反应,而不会干扰赖氨酸的再活动.该化合物有两种氟酸甘烃组群,一种是阿尔法氨基组群的,另一种是普西隆氨基甘油组群体的,这加强了其在有机溶剂中的稳定性和溶性.这些保护群体的存在通过在混合过程中防止不必要的侧面反应,促进了酸的合成.此外,N(alpha),N(epsilon)-di-foc-L-lysine在温和的基本条件下可以放松保护,允许必要时释放免费氨基氨基质组体.其结构特征有助于其在开发各种生物药理学和在浸泡化学方面的研究应用.总体而言,该化合物的多变性和有效性被评估,以促进复杂的石化合成结构.

结构式图片

相似化合物

75932-02-4 10009-20-8 105047-45-8

欧盟法规

C&L通报

上下游产品

L-lysine N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide L-Lysine hydr°Chloride (fluorenylmethoxy)carbonyl chlorideL-lysine (S)-2,6-Diamino-hexanoic acid {2-[2-(2,4-dichloro-phenoxy)-acetylamino]-ethyl}-amide α,Nε-bis-Fm°C-L-Lys)-O-(4,4'-dimethoxytrityl)-O'-(tert-butyldimethylsilyl)diethanolamineN-(Nα,Nε-bis-Fm°C-L-Lys)-O-(4,4'-dimethoxytrityl)-O'-(tert-butyldimethylsilyl)diethanolamine

合成工艺路线路线简述

    9-芴甲基-N-琥珀酰亚胺基碳酸酯 反应生成 N,N'-双芴甲氧羰基-L-赖氨酸
    参考文献:Fujii,Nobutaka;Futaki,Shiroh;Funakoshi,Susumu;Akaji,Kenichi;Morimoto,+,Chem. And Pharm. Bull.,36,(1988) N 9,C. 3281-3291
    标题:Fujii,Nobutaka;Futaki,Shiroh;Funakoshi,Susumu;Akaji,Kenichi;Morimoto,+,Chem. And Pharm. Bull.,36,(1988) N 9,C. 3281-3291

    海关参考信息

    专利信息


    专利号:US-2024336649-A1
    优先权日:2021-06-21
    标 题 :Synthesis of covalent protein dimers that can inhibit myc-driven transcription
    发明人:LOAS ANDREI; PENTELUTE BRADLEY L; POMPLUN SEBASTIAN; JBARA MUHAMMAD; SCHISSEL CARLY KATHERINE; RODRIQUEZ JACOB JOSHUA LEE; BUCHWALD STEPHEN LEFFLER; BOIJA ANN; KLEIN ISAAC; HAWKEN SUSANA WILSON; LI CHARLES HAN
    权利人:MASSACHUSETTS INST TECHNOLOGY; WHITEHEAD INSTITUTE OF BIOMEDICAL RES
    摘要:The disclosure relates to covalent protein dimers of MYC, MAX, and Omomyc; pharmaceutical compositions comprising the covalent protein dimers; methods of making the covalent protein dimers; and methods of treating disorders associated with MYC dysregulation (e.g., cancer) with the covalent protein dimers.

    专利号:US-6175020-B1
    优先权日:1999-04-09
    标题 :Spirodiamino acid scaffold for combinatorial synthesis
    发明人:DOLLE III ROLAND ELLWOOD; BARDEN MICHAEL C
    权利人:PHARMACOPEIA INC
    摘要:Azaspirononanes of formula I and their synthesis n are disclosed. The compounds are useful as templates for constructing synthetic receptors and as intermediates in the synthesis of enzyme inhibitors. They are prepared by an intramolecular ylide cycloaddition of a 6-hydrazone of 2,10-undecadienoic acid ester.

    专利号:US-8178474-B1
    优先权日:1999-04-21
    标题 :Functionalised solid support for alpha-oxoaldehyde synthesis
    发明人:MELNYK OLEG; FRUCHART JEAN-SEBASTIEN; BOUREL LINE; GRAS-MASSE HELENE
    权利人:MELNYK OLEG; FRUCHART JEAN-SEBASTIEN; BOUREL LINE; GRAS-MASSE HELENE; PASTEUR INSTITUT; CENTRE NAT RECH SCIENT
    摘要:The invention relates to a functionalised solid support for the synthesis of compounds comprising at least one α-oxoaldehyde function, to a process for preparing it and to its applications, in particular for the preparation of a library of organic compounds, of a diagnostic reagent, of a microtitration plate and of a biochip, such as a DNA chip. The present invention also relates to a process for the synthesis of organic compounds comprising at least one α-oxoaldehyde function and to the α-oxoaldehyde peptides obtained using this process.

    专利号:US-8450469-B2
    优先权日:2008-01-21
    标 题:Synthesis of peptide nucleic acids conjugated with amino acids and their application
    发明人:LEE HYUNIL; MIN JUNG HYUN
    权利人:LEE HYUNIL; MIN JUNG HYUN; PANAGENE INC
    摘要:This invention relates to a peptide nucleic acid (PNA) oligomer which is conjugated with one or more linear-type amino acid containing a plurality of alkyleneglycols and to a synthesis method thereof. In addition, this invention related to a linear amino acid spacer in a device for detection for detecting a target gene using the PNA oligomers which is fixed on a surface of a functionalized solid support. The linear amino acid spacer contains a plurality of alkyleneglycols and maintains enough space between the solid support and PNA oligomer in the device in order to prevent the interference of the interaction between the PNA oligomer and a target gene. Furthermore, this invention relates to a PNA array, a PNA chip and a gene diagnosis kit whereof sensitivity and specificity are improved by being manufactured with the PNA conjugated with the amino acid spacer.

    专利号:US-6191277-B1
    优先权日:1998-04-29
    标 题:Hydroxypropylamide peptidomimetics as inhibitors of aspartyl proteases
    发明人:DOLLE III ROLAND ELLWOOD; CAVALLARO CULLEN LEE; HERPIN TIMOTHEE FELIX
    权利人:PHARMACOPEIA INC
    摘要:Compounds of Formula Iare disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathsepsin D. The compounds are useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is a heterocycle, amide, sulfonamide or carbamate and Z is an acyl or a functionalized acyl. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid phase support, are also disclosed.

    专利号:US-2025231184-A1
    优先权日:2022-10-12
    标题:Nitrilotriacetic acid linkers, solid phase synthesis of nitrilotriacetic acid linkers and applications thereof
    发明人:JAMALI HOJJAT S
    权利人:NICOYA LIFESCIENCES INC
    摘要:Described are devices, compounds and methods for detecting an analyte in a sample. More particularly this disclosure provides SPR and LSPR sensors modified by NTA linkers for binding a ligand and/or analyte. The NTA linkers of the disclosure typically include a head (or “anchoring siteâ€?) for coupling to a surface of the SPR or LSPR sensor, a spacer, and one or more attachment sites on a distal end or ends of the spacer which couple to a ligand. The head may include a thiol for coupling the linker to a surface of the SPR or LSPR sensor. The spacer may be a carbon chain. PAG or PEG chain, or matrix material. The one or more attachment sites may be a nitrilotriacetic acid (NTA) moiety capable of chelating a transition metal ion and binding the ligand.
    湖北恒绿源科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.hbhlykj.com
    企业联系电话:027-88188016👤
    📞湖北恒绿源科技有限公司 ⚠️参考联系方式
    联系人:高婕
    电话:027-88188016
    手机:18062414339
    传真:027-88188026
    邮箱:sales@hbhlykjtech.com
    通信地址: 湖北省武汉市江岸区黄孝河路182号
    邮编: 430012
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市江岸区黄孝河路182号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海吉尔多肽有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.glbiochem.com
    电话: 86-21-61263309👤
    📞上海吉尔多肽有限公司 ⚠️参考联系方式

    销售电话:86-21-61263309
    邮箱:ymbetter@glbiochem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: Luckose F, Et Al. Effects Of Amino Acid Derivatives On Physical, Mental, And Physiological Activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.
    [参考文献]: Joseph R Merrill, Et Al. Synthesis And Comparative Evaluation Of Novel (64)Cu-Labeled High Affinity Cell-Specific Peptides For Positron Emission Tomography Imaging Of Tumor Vasculature. Biomaterials. 2016 Apr:84:241-249.

    合成参考文献


    参考文献:10.1385/1-59259-813-7:207
    摘要:Kaihatsu K, Corey DR. Synthesis of peptide nucleic acid-peptide conjugates. Methods Mol Biol. 2004;283():207–14. doi: 10.1385/1-59259-813-7:207.
    参考文献:10.1038/s41596-019-0181-3
    摘要:Chavez JD, Mohr JP, Mathay M, Zhong X, Keller A, Bruce JE. Systems structural biology measurements by in vivo cross-linking with mass spectrometry. Nature Protocols. 2019 Jul 03;14(8):2318–43. doi: 10.1038/s41596-019-0181-3.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知